| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Scientific &Med Officer | SVP Chief Medical Officer
2 companies
Febbo Phillip G. is a Chief Scientific &Med Officer at VERACYTE, INC. with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 12 sells.
Estimated insider holdings value: $5.7M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 6, 2025 | VCYT Veracyte, Inc. | Chief Scientific &Med Officer | Sell | 8,349 | $36.02 | $300,709.27 | -8.3% | +21.1% | - | |
| Mar 4, 2025 | VCYT Veracyte, Inc. | Chief Scientific &Med Officer | Sell | 8,037 | $33.35 | $268,012.94 | -4.5% | -21.6% | +6.3% | |
| Dec 4, 2024 | VCYT Veracyte, Inc. | Chief Scientific &Med Officer | Sell | 3,934 | $44.09 | $173,447.31 | -4.6% | -22.6% | +7.5% | |
| Apr 6, 2022 | ILMN Illumina, Inc. | SVP Chief Medical Officer | Sell | 1,988 | $360.01 | $715,699.88 | -25.6% | -46.2% | -35.9% | |
| Nov 8, 2021 | ILMN Illumina, Inc. | SVP Chief Medical Officer | Sell | 1,000 | $406.83 | $406,830.00 | -24.9% | -11.5% | -45.8% | |
| Jun 11, 2021 | ILMN Illumina, Inc. | SVP Chief Medical Officer | Sell | 1,000 | $447.59 | $447,588.50 | -6.5% | +1.3% | -54.9% | |
| Nov 6, 2020 | ILMN Illumina, Inc. | SVP Chief Medical Officer | Sell | 155 | $310.10 | $48,065.50 | -6.7% | - | - | |
| Apr 16, 2020 | ILMN Illumina, Inc. | SVP Chief Medical Officer | Sell | 173 | $300.00 | $51,900.00 | -6.5% | - | - | |
| Nov 14, 2019 | ILMN Illumina, Inc. | SVP Chief Medical Officer | Sell | 155 | $300.00 | $46,500.00 | -9.3% | - | - |